+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Polymer Microfluidic Chips for in Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6135523
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Polymer Microfluidic Chips for in Vitro Diagnostics Market is projected to reach USD 890.12 Million in 2026. It is expected to continue growing at a CAGR of 12.31%, reaching USD 1.77 Billion by 2032.

Polymer Microfluidic Chips Enable Compact, Scalable In Vitro Diagnostics

Polymer microfluidic chips integrate sample preparation, fluid handling, reaction control, and detection within compact devices. Their relevance to in vitro diagnostics is driven by demand for faster workflows, lower sample volumes, decentralized testing, and increasingly automated laboratory processes. Material selection, surface treatment, manufacturing precision, assay compatibility, and regulatory validation remain central to commercial adoption.

Manufacturing Scale and Decentralized Testing Are Reshaping Adoption

The landscape is shifting from laboratory-centered workflows toward portable, near-patient, and distributed testing formats. Advances in injection molding, hot embossing, laser processing, bonding, and surface modification are improving repeatability while supporting high-volume production. At the same time, diagnostic developers are prioritizing integrated cartridges that reduce manual handling and support multiplexed assays. Persistent challenges include polymer autofluorescence, nonspecific adsorption, reagent stability, batch-to-batch variation, waste management, and the need to validate performance across diverse clinical samples.

Artificial Intelligence Strengthens Design, Quality Control, and Diagnostic Interpretation

Artificial intelligence is contributing across the device lifecycle. Machine-learning methods can support microchannel design, fluid-flow simulation, assay optimization, and prediction of surface interactions. In manufacturing, computer vision can identify defects, monitor bonding quality, and improve process consistency. Within diagnostic systems, algorithms may assist image analysis, signal interpretation, anomaly detection, and workflow triage. Effective deployment still depends on representative training data, explainability, cybersecurity, software validation, and clear separation between device performance evidence and algorithmic claims.

Regional Conditions Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America benefits from advanced diagnostic infrastructure, strong translational research, and established regulatory pathways, while procurement and reimbursement requirements remain important adoption filters. Europe combines sophisticated healthcare systems with rigorous conformity and data-governance expectations, encouraging strong evidence generation. Asia-Pacific spans mature manufacturing and research ecosystems alongside rapidly expanding diagnostic access, creating opportunities for both high-throughput laboratory platforms and decentralized systems. Latin America is shaped by uneven laboratory capacity, import dependence, and demand for robust, cost-conscious testing. The Middle East is emphasizing healthcare modernization and local capability, whereas Africa presents substantial need for portable, affordable diagnostics alongside infrastructure, supply-chain, and workforce constraints.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Reflect Distinct Priorities

ASEAN markets emphasize affordable access, regional supply resilience, and adaptable diagnostic platforms across varied healthcare systems. BRICS members represent diverse combinations of domestic manufacturing, public-health demand, research capacity, and regulatory maturity, making localization important. The European Union prioritizes harmonized regulation, laboratory quality, sustainability, and data protection. G7 economies generally place greater weight on clinical evidence, cybersecurity, advanced automation, and resilient supply chains. GCC countries are investing in modern healthcare infrastructure and specialized testing, while NATO countries collectively underscore preparedness, interoperability, and secure medical supply networks, although commercial requirements remain nationally determined.

Country-Level Priorities Range from Manufacturing Scale to Decentralized Access

Australia emphasizes geographic reach, quality assurance, and decentralized testing. Brazil and Mexico face varied regional access and benefit from solutions compatible with constrained laboratory environments. Canada and the United States combine advanced research with demanding evidence, reimbursement, and procurement expectations. China, India, Japan, and South Korea offer strong capabilities in electronics, precision manufacturing, diagnostics, or life-science research, while differing regulatory and localization requirements shape entry strategies. France, Germany, Italy, Spain, and the United Kingdom place substantial importance on clinical validation, quality systems, sustainability, and integration with established healthcare pathways. Russia’s operating environment is influenced by domestic production priorities, regulatory conditions, and supply-chain considerations.

Prioritize Assay Fit, Manufacturability, Evidence, and Regional Resilience

Industry leaders should select polymers and surface treatments against the complete assay workflow rather than material cost alone. Design-for-manufacture reviews should begin early and address bonding, optical performance, reagent storage, tolerances, sterilization, and disposal. Partnerships with clinical laboratories can generate evidence under real operating conditions, including operator variability and imperfect samples. Regional strategies should adapt to procurement, reimbursement, regulatory, and infrastructure realities, while dual sourcing and localized production can reduce supply disruption. AI should be introduced through validated, auditable applications with strong data governance and human oversight.

Methodology Combines Structured Secondary Review with Technical and Regulatory Synthesis

This executive summary uses a structured assessment of the polymer microfluidic chip landscape for in vitro diagnostics, organized around technology development, manufacturing, clinical workflow, regulation, infrastructure, and regional adoption conditions. Insights are synthesized from publicly available technical literature, regulatory materials, standards-oriented documentation, healthcare and trade publications, and reported industry developments. Findings are compared across the specified regions, country groups, and countries, with emphasis on evidence-supported themes rather than market estimates. Because platform performance varies by polymer, assay, instrument, and intended use, conclusions should be interpreted in the context of the relevant diagnostic application and validation stage.

Execution Will Depend on Translating Microfluidic Advantages into Verified Clinical Utility

Polymer microfluidic chips offer a practical route to smaller, faster, and more integrated in vitro diagnostic workflows, but adoption depends on more than miniaturization. Successful platforms must demonstrate reliable fluid control, assay stability, manufacturability, clinical performance, regulatory compliance, and operational value. Leaders that align material science, automation, artificial intelligence, evidence generation, and regional delivery models will be better positioned to convert technical capability into dependable diagnostic use.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Material Type
7.1. Introduction
7.2. Coc
7.3. Pc
7.4. Pdms
7.5. Pmma
7.6. Ps
8. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Detection Method
8.1. Introduction
8.2. Electrochemical Detection
8.2.1. Amperometric
8.2.2. Potentiometric
8.3. Fluorescence Detection
8.4. Mass Spectrometry
8.5. Optical Detection
8.5.1. Colorimetric
8.5.2. Refractive Index
9. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Technology
9.1. Introduction
9.2. Continuous Flow Microfluidics
9.3. Droplet Based Microfluidics
9.3.1. Digital Pcr
9.3.2. Single Cell Analysis
10. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Fabrication Method
10.1. Introduction
10.2. 3D Printing
10.2.1. Fdm
10.2.2. Sla
10.3. Hot Embossing
10.4. Injection Molding
10.5. Laser Ablation
10.6. Photolithography
11. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Application
11.1. Introduction
11.2. Cancer Diagnostics
11.3. Genetic Testing
11.3.1. Polymerase Chain Reaction Chips
11.3.2. Sequencing Platforms
11.4. Immunoassay
11.5. Infectious Disease Testing
11.5.1. Covid-19 Testing
11.5.2. Hiv Testing
11.5.3. Tb Testing
11.6. Point Of Care Testing
11.6.1. Glucose Monitoring
11.6.2. Infectious Disease Rapid Tests
11.6.3. Pregnancy Testing
12. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals & Clinics
12.5. Pharmaceutical & Biotech Companies
13. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Polymer Microfluidic Chips for in Vitro Diagnostics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Agilent Technologies Inc.
17.3. Becton Dickinson (BD)
17.4. Bio-Rad Laboratories Inc.
17.5. Danaher Corporation
17.6. Elveflow
17.7. Fluigent SAS
17.8. Microfluidic ChipShop GmbH
17.9. Micronit Microtechnologies B.V.
17.10. PerkinElmer Inc.
17.11. Roche Holding AG
17.12. Siemens Healthineers
17.13. Standard BioTools Inc.
17.14. Thermo Fisher Scientific Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market, Research Design
FIGURE 3. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market, Research Framework
FIGURE 4. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market, Data Triangulation
FIGURE 5. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 7. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2025 vs 2032 (%)
FIGURE 9. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2025 vs 2032 (%)
FIGURE 13. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Segmentation & Coverage
TABLE 2. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 4. Global Coc Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Coc Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Coc Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pc Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pc Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pc Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Pdms Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Pdms Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Pdms Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pmma Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pmma Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pmma Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Ps Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Ps Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Ps Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 20. Global Electrochemical Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Electrochemical Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Electrochemical Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Amperometric Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Amperometric Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Amperometric Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Potentiometric Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Potentiometric Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Potentiometric Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Fluorescence Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Fluorescence Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Fluorescence Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Optical Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Optical Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Optical Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Colorimetric Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Colorimetric Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Colorimetric Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Refractive Index Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Refractive Index Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Refractive Index Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 45. Global Continuous Flow Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Continuous Flow Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Continuous Flow Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Droplet Based Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Droplet Based Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Droplet Based Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Single Cell Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Single Cell Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Single Cell Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 58. Global 3D Printing Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global 3D Printing Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global 3D Printing Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Fdm Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Fdm Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Fdm Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Sla Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Sla Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Sla Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hot Embossing Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hot Embossing Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hot Embossing Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Injection Molding Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Injection Molding Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Injection Molding Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Laser Ablation Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Laser Ablation Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Laser Ablation Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Photolithography Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Photolithography Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Photolithography Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Global Cancer Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Cancer Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Cancer Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Polymerase Chain Reaction Chips Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Polymerase Chain Reaction Chips Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Polymerase Chain Reaction Chips Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Sequencing Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Sequencing Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Sequencing Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Infectious Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Covid-19 Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Covid-19 Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Covid-19 Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Hiv Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Hiv Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Hiv Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Tb Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Tb Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Tb Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Point Of Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Point Of Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Point Of Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Glucose Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Glucose Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Glucose Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Infectious Disease Rapid Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Infectious Disease Rapid Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Infectious Disease Rapid Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Pregnancy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Pregnancy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Pregnancy Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Pharmaceutical & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Pharmaceutical & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Pharmaceutical & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 149. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 150. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 151. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 152. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 154. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 155. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 156. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 158. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 159. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 160. North America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 163. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 164. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 165. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 166. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 168. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 169. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 170. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 172. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 173. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 174. Latin America Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 177. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 178. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 179. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 180. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 182. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 183. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 184. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 186. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 187. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 188. Europe Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 191. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 192. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 193. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 194. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 196. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 197. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 198. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 200. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 201. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 202. Middle East Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 205. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 206. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 207. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 208. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 210. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 211. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 212. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 214. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 215. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 216. Africa Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 220. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 221. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 222. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 223. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 225. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 226. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 227. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 229. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 230. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 231. ASEAN Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 234. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 235. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 236. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 237. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 239. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 240. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 241. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 243. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 244. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 245. GCC Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 248. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 249. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 250. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 251. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 253. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 254. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 255. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 257. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 258. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 259. European Union Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 262. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 263. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 264. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 265. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 267. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 268. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 269. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 271. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 272. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 273. BRICS Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 276. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 277. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 278. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 279. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 281. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 282. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 283. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 285. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 286. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Point Of Care Testing, 2017-2032 (USD Million)
TABLE 287. G7 Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 290. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 291. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 292. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Optical Detection, 2017-2032 (USD Million)
TABLE 293. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Droplet Based Microfluidics, 2017-2032 (USD Million)
TABLE 295. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Fabrication Method, 2017-2032 (USD Million)
TABLE 296. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by 3D Printing, 2017-2032 (USD Million)
TABLE 297. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. NATO Polymer Microfluidic Chips for in Vitro Diagnostics Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 299. NATO Polymer Micr

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson (BD)
  • Bio‑Rad Laboratories Inc.
  • Danaher Corporation
  • Elveflow
  • Fluigent SAS
  • Microfluidic ChipShop GmbH
  • Micronit Microtechnologies B.V.
  • PerkinElmer Inc.
  • Roche Holding AG
  • Siemens Healthineers
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.